| Document and Entity Information | 9 Months Ended |
| May 31, 2019shares | |
| Document And Entity Information | |
| Entity Registrant Name | BIOHEMP INTERNATIONAL, INC. |
| Entity Central Index Key | 0001556416 |
| Document Type | 10-Q |
| Amendment Flag | false |
| Current Fiscal Year End Date | --08-31 |
| Entity Small Business | true |
| Entity Emerging Growth Company | true |
| Entity Current Reporting Status | Yes |
| Document Period End Date | May 31, 2019 |
| Entity Filer Category | Non-accelerated Filer |
| Document Fiscal Period Focus | Q3 |
| Document Fiscal Year Focus | 2019 |
| Entity Shell Company | false |
| Entity Ex Transition Period | true |
| Entity Common Stock Shares Outstanding | 2,487,063 |
| Balance Sheets - USD ($) | May 31, 2019 | Aug. 31, 2018 |
| Balance Sheets | ||
| Cash | ||
| Total Current Assets | ||
| TOTAL ASSETS | ||
| Notes payable | 112,500 | 139,500 |
| Accounts payable | 39,141 | 31,533 |
| Accounts payable-related party | 30,827 | 21,040 |
| Due to related party | 11,637 | 11,637 |
| Accrued interest | 43,266 | 32,955 |
| Total Current Liabilities | 237,371 | 236,665 |
| Total Liabilities | 237,371 | 236,665 |
| Preferred stock ($0.0001 par value; 10,000,000 authorized; no shares issued and outstanding) | ||
| Common stock ($0.0001 par value, 100,000,000 shares authorized; 2,487,063 (2019-32,517)) shares issued and outstanding) | 249 | 3 |
| Additional paid-in capital | 247,686 | 220,932 |
| Deficit accumulated during the development stage | (485,306) | (457,600) |
| Total Stockholders' Equity (Deficit) | (237,371) | (236,665) |
| TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT) |
| Balance Sheets (Parenthetical) - $ / shares | May 31, 2019 | Aug. 31, 2018 |
| Balance Sheets | ||
| Preferred stock, par value | $ 0.0001 | $ 0.0001 |
| Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
| Preferred stock, shares issued | 0 | 0 |
| Preferred stock, shares outstanding | 0 | 0 |
| Common stock, par value | $ 0.0001 | $ 0.0001 |
| Common stock, shares authorized | 100,000,000 | 100,000,000 |
| Common stock, shares issued | 2,487,063 | 32,517 |
| Common stock, shares outstanding | 2,487,063 | 32,517 |
| Statements of Cash Flows (Unaudited) - USD ($) | 9 Months Ended | |
| May 31, 2019 | May 31, 2018 | |
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Net Loss | $ (27,706) | $ (24,065) |
| Changes in operating assets and liabilities: | ||
| Increase (decrease) in accounts payable | 17,395 | 13,602 |
| Increase (decrease) in accrued interest | 10,311 | 10,463 |
| Net cash (used in) operating activities | ||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Proceeds from notes paybable | ||
| Net cash provided by financing activities | ||
| Net increase (decrease) in cash | ||
| Cash at beginning of period | 84 | |
| Cash at end of period | $ 84 | |
| Supplemental Disclosures of Cash Flow Information: | ||
| Cash Paid For: | ||
| Interest | ||
| Income Taxes | ||
| Non cash transactions | ||
| Shares issued for debt | 27,000 | |
| Statement of Changes in Stockholders' Equity - USD ($) | Total | Common Stock | Additional Paid-in Capital | Deficit |
| Balances, Shares at Aug. 31, 2017 | 32,517 | |||
| Balances, Amount at Aug. 31, 2017 | $ (191,464) | $ 3 | $ 220,932 | $ (412,939) |
| Net loss | (24,065) | (24,065) | ||
| Balance, Shares at May. 31, 2018 | 32,517 | |||
| Balance, Amount at May. 31, 2018 | (191,464) | $ 3 | 220,932 | (437,004) |
| Balances, Shares at Aug. 31, 2018 | 32,517 | |||
| Balances, Amount at Aug. 31, 2018 | (236,665) | $ 3 | 220,932 | (457,600) |
| Net loss | (27,706) | (27,706) | ||
| Conversion of notes payable to shares, Shares | 2,454,546 | |||
| Conversion of notes payable to shares, Amount | 27,000 | $ 246 | 26,754 | |
| Balance, Shares at May. 31, 2019 | 2,487,063 | |||
| Balance, Amount at May. 31, 2019 | $ (237,371) | $ 249 | $ 247,686 | $ (485,306) |
| GOING CONCERN CONSIDERATION (Details Narrative) - USD ($) | May 31, 2019 | Aug. 31, 2018 |
| GOING CONCERN CONSIDERATION (Details Narrative) | ||
| Deficit accumulated during the development stage | $ (485,306) | $ (457,600) |
| MATERIAL AGREEMENTS (Details Narrative) | Mar. 12, 2019shares |
| FJ Investments International Inc [Member] | |
| Common stock shares reserved for future issuance | 25,000,000 |
| NOTES PAYABLE (Details Narrative) - USD ($) | Apr. 19, 2017 | Mar. 17, 2017 | Sep. 19, 2016 | Jul. 29, 2016 | Dec. 10, 2015 | Jun. 24, 2015 | Jan. 18, 2015 | Nov. 20, 2014 | Aug. 31, 2014 |
| NOTES PAYABLE (Details Narrative) | |||||||||
| Promissory note payable | $ 20,000 | $ 10,000 | $ 42,000 | $ 15,000 | $ 15,000 | $ 12,500 | $ 10,000 | $ 10,000 | $ 5,000 |
| Promissory note payable, interest rate | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% |
| RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) | May 31, 2019 | Feb. 28, 2019 | Aug. 31, 2018 |
| RELATED PARTY TRANSACTIONS (Details Narrative) | |||
| Due to related party | $ 11,637 | $ 11,637 | $ 11,637 |
| STOCKHOLDERS' EQUITY (Details Narrative) - $ / shares | May 31, 2019 | Aug. 31, 2018 | Aug. 31, 2012 |
| STOCKHOLDERS' EQUITY (Details Narrative) | |||
| Preferred stock par value | $ 0.0001 | $ 0.0001 | $ 0.0001 |
| Preferred stock shares authorized | 10,000,000 | 10,000,000 | 10,000,000 |
| Common stock par value | $ 0.0001 | $ 0.0001 | $ 0.0001 |
| Common stock shares authorized | 100,000,000 | 100,000,000 | 100,000,000 |
| Common stock shares issued | 2,487,063 | 32,517 | |
| Common stock shares outstanding | 2,487,063 | 32,517 |
